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Streptococcus pneumoniae is not commonly consid-
ered an agent of urinary tract infections. We report 3 chil-
dren with urinary tract abnormalities who had high numbers 
of S. pneumoniae in their urine (>104 CFU/mL) and varying 
clinical symptoms.
T
he role of Streptococcus pneumoniae as an agent of 
septicemia, pneumonia, and meningitis is well known 
(1,2). However, published reports of urinary tract infec-
tion (UTI) associated with S. pneumoniae are scarce, and 
S. pneumoniae generally is not considered an agent of UTI 
in either adults or children (3,4). We report 3 children with 
urinary tract abnormalities and high levels of S. pneumo-
niae in their urine.
Case Reports
In June 2008, a 23-month-old boy (case-patient 1) 
received care for fever and clinical signs of a UTI at the 
emergency department of the University of Heidelberg 
Children’s Hospital. He did not show signs of respiratory 
disease. His medical history was remarkable for bilateral 
cystic–dysplastic kidneys, a congenital urethral valve (sur-
gery in October 2006), terminal kidney insufﬁ  ciency and 
peritoneal dialysis since 2006, renal anemia, hyperparathy-
roidism, hyperphosphatemia, microcephalus, and failure to 
thrive. Blood was drawn for culture, and a urine sample 
was taken. After 9 hours of incubation, the blood culture 
was positive for S. pneumoniae, and the urine grew 105 
CFU/mL of S. pneumoniae. Blood leukocyte levels were 
elevated (20 cells/nL [normal <13 cells/nL]), as were leu-
kocyte levels in the urine (568 cells/μL [normal <4 cells/
μL]). A throat swab was negative for S. pneumoniae. The 
boy’s infection was treated successfully, and he was dis-
charged 4 days after admission. Further analysis showed 
that both isolates were serotype 15B and were fully suscep-
tible to all antibacterial drugs tested (Table 1).
In September 2009, a 12-year-old boy (case-patient 2) 
sought care at the nephrology department of the University 
of Heidelberg Children’s Hospital for his yearly control ex-
amination 7 years after kidney transplantation. He had no 
clinical signs of current infection. His medical history was 
remarkable for kidney insufﬁ  ciency, congenital obstruc-
tion and reﬂ  ux in the urethral valve, kidney transplantation 
in 2002, ileocecal pouch, chronic transplant nephropathy, 
metabolic acidosis, hypertension, and renal anemia. A 
urine sample showed 105 CFU/mL S. pneumoniae and 103 
CFU/mL Enterobacteriaceae. Urine leukocyte levels were 
slightly elevated (16 cells/μL). Further analysis showed 
that S. pneumoniae was serotype 34 and fully susceptible 
to all antibacterial drugs tested (Table 1).
In November 2009, a 7-year-old girl (case-patient 3) 
was sent to the emergency department of the University 
of Heidelberg Children’s Hospital  by her pediatrician be-
cause of abnormal results in a control urine sample 4 weeks 
after percutaneous nephrolithoapraxia and concrement re-
moval. She was known to have cystinuria and had already 
undergone extracorporeal shock wave treatment with con-
crement removal in 2004. Her temperature was slightly el-
evated (37.5°C), but she had no dysuria or pain. Urinaly-
sis showed elevated leukocyte levels (158 cells/μL), and 
104 CFU/mL S. pneumoniae could be grown. Because of 
the mild symptoms, no antimicrobial drug treatment was 
started. Further analysis showed that the isolate was a 19F 
serotype (Table 1).
For each patient, urine was routinely cultured as fol-
lows: 2 samples of 1 μL each were placed on a 5% sheep-
blood agar plate and a MacConkey agar plate. chromID 
CPS medium (bioMérieux, Nürtingen, Germany) was in-
jected with 10 μL of urine. All plates were incubated for 
18–24 h at 36°C ± 1°C in ambient air (5). Susceptibility 
testing was performed by using the BD Phoenix Automated 
Microbiology System with SMIC/ID panels (Becton Dick-
inson, Heidelberg, Germany).
Discussion and Conclusions
The literature on urinary tract infections with S. pneu-
moniae is scarce. In 1980, Green and Selinger described 
a patient with a soft tissue abscess and a UTI caused by 
serotype 3 (6). In 2004, Dufke et al. described a patient 
with pyelonephritis and urosepsis caused by serotype 6A 
(7). In 1988, Nguyen and Penn  determined the frequency 
of pneumococci in urine specimens from adults and found 
38 (0.18%) of 22,744 samples positive for S. pneumoniae 
(4). Similarly,  Miller et al. determined that the frequency 
of pneumococci in urine specimens from children was even 
lower: 43 (0.08%) of 53.499 samples (3). Of 28 patients, 
for whom clinical data were available, 5 had dysuria, and 
2 had pyuria. Three asymptomatic children had medical 
histories of genitourinary abnormalities; 6 asymptomatic 
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children had medical histories of recurrent UTI with Enter-
obacteriaceae. The serotypes and antibiotic susceptibilities 
of the respective isolates were not reported.
A UTI is deﬁ   ned as bacteriuria (>105 CFU/mL in 
adults, >104 CFU/mL in children) of 1 uropathogen and 
typical clinical signs, i.e., dysuria and urgency. Depend-
ing on the age of the patient, clinical signs might be less 
typical, especially in children <2 years of age. Generally 
pyuria is present (8,9). By contrast, asymptomatic bacte-
riuria is deﬁ  ned as a uropathogen (>105 CFU/mL in adults, 
>104 CFU/mL in children) without pyuria (<10 leukocytes/
μL) (9).
Applying these criteria to the 3 cases in this report 
yields the following results. Assuming that S. pneumoniae 
is a uropathogen, case 1 is a UTI accompanied by septice-
mia. No other focus of infection with S. pneumoniae was 
apparent or could be identiﬁ  ed. We believe this is an as-
cending UTI in a boy with known oliguria from bilateral 
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Table 1. Characteristics of Streptococcus pneumoniae isolates in 3 children with chronic kidney disease, Germany, 2005–2010* 
Characteristic Case 1  Case 2  Case 3 
Sample Blood Urine Urine  Urine 
Serotype 15B 15B 34 19F 
Optochin S S S S
Bile solubility  Positive  Positive  Positive  Positive 
Oxacillin, 1 μg S S S S
Penicillin <0.03 S <0.03 S <0.03 S 0.06 S
Amoxicillin <0.25 S <0.25 S <0.25 S <0.25 S
Cefotaxime <0.5 S <0.5 S <0.5 S <0.5 S
Erythromycin <0.06 S <0.06 S <0.06 S >4.0 R
Clindamycin 0.06 S 0.06 S 0.06 S >2R
Tetracycline <0.5 S <0.5 S <0.5 S >8R
Levofloxacin 1 S 1 S <0.5 S 1.0 S
Meropenem <0.125 S <0.125 S <0.125 S <0.125 S
Vancomycin <0.5 S <0.5 S <0.5 S <0.5 S
Linezolid <1S < 1S < 1S < 1S
Moxifloxacin <0.25 S <0.25 S <0.25 S <0.25 S
Co-trimoxazole 1/19 I 1/19 I d0.5/9.5  S< 0.5/9.5 S
*Values are MICs (mg/mL). S, susceptible; R, resistant; I, intermediate. 
Table 2. Results of urine samples of 12-year-old boy with chronic kidney disease, Germany, 2005–2010 
Date sample arrived 
in laboratory  Type of urine sample  CFU/mL  Species
Leukocyte count, 
cells/μL 
2005 Apr  Catheter   10
5 D-Hemolytic streptococci*  No data 
10
4 Proteus mirabilis
2005 Jul  Midstream 10
5 D-Hemolytic streptococci  No data 
10
5 Proteus mirabilis
2005 Sep  Midstream 10
5 Streptococcus pyogenes No data 
10
3 D-Hemolytic streptococci 
2007 Mar  Midstream 10
4 Streptococcus pneumoniae 92
10
4 Proteus mirabilis
2008 Mar  Midstream 10
4 D-Hemolytic streptococci  54
10
4 Proteus mirabilis
2008 Jun  Midstream 10
5 Proteus mirabilis 33
10
3 D-Hemolytic streptococci 
2008 Jul  Midstream 10
5 D-Hemolytic streptococci  150
2008 Nov  Midstream 10
4 D-Hemolytic streptococci  90
2009 Mar  Midstream 10
5 D-Hemolytic streptococci  46
2009 May  Midstream 10
5 D-Hemolytic streptococci  24
10
4 Proteus mirabilis
2009 Sep  Midstream 10
5 Streptococcus pneumoniae 16
10
3 Enterobacteriaceae 
2010 Jan  Midstream 10
5 D-Hemolytic streptococci  94
10
4 Proteus mirabilis
2010 Jun  Midstream 10
5 D-Hemolytic streptococci  124
10
4 Proteus mirabilis
*Reference value is <4 cells/μL. cystic–dysplastic kidneys. Because case-patient 3 showed 
only mild symptoms, diagnosis of UTI is not obligatory. 
Nevertheless, it is not a mere pneumococcosuria because 
of the high numbers of leukocytes in the urine (158 cells/
μL).
Case 2 is more difﬁ  cult to classify. The episode de-
scribed might be pneumococcosuria because the leukocyte 
level is not high; nevertheless, it is above normal. Reas-
sessment of all microbiological data of case-patient 2 indi-
cated that since 2005 we have received 29 different urine 
samples. In March 2007, we had already identiﬁ  ed S. pneu-
moniae (104 CFU/mL) and pyuria (92 CFU/μL). Addition-
ally, 104 CFU/mL Proteus mirabilis had been present and 
considered the cause of the pyuria; 11 of 27 samples had 
contained α-hemolytic streptococci >103 CFU/mL (Table 
2). Unfortunately, no test to differentiate between pneumo-
cocci and the other α-hemolytic streptococci was originally 
performed on these bacteria. Therefore, we can only specu-
late whether at least some of these samples contained S. 
pneumoniae. Taking these facts into account, we believe 
that this might be a case of bacterial persistence according 
to the criteria described by Chang and Shortliffe (cultures 
± same organism) (8).
Reassessment of all available laboratory data on case-
patient 1 showed that we received 3 urine samples before 
the described episode and 8 afterward. In none of the sam-
ples did we ﬁ  nd S. pneumoniae or α-hemolytic streptococci. 
From case-patient 3 we did not receive any other material 
than described.
Further analysis of the S. pneumoniae isolates indicat-
ed that all 3 children were affected by different serotypes. 
Therefore, we do not have an indication that a single se-
rotype has a predilection for the urinary tract. In theory, 2 
cases could have been avoided by vaccination, i.e., case 3 
(serotype 19F) and case 1 (serotype 15B). However, case-
patient 3 was 4 years of age when the routine vaccination 
program aimed at children <2 years of age started in Ger-
many in 2006. Because no catch-up program existed, this 
child was never vaccinated against pneumococci. Case-
patient 1 was regularly vaccinated with heptavalent pneu-
mococcal conjugate vaccine in 2006–2007 but was just 23 
months old at disease onset disease, i.e., 1 month too young 
to be eligible for the 23-valent pneumococcal polysaccha-
ride vaccine. Case-patient 2 is not yet vaccinated against 
pneumococci. Thus, we suggest that S. pneumoniae be 
added to the potential UTI-causing pathogens in children 
with urinary tract abnormalities.
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